Grantham, Mayo, Van Otterloo & Co (GMO)
CMD

Grantham, Mayo, Van Otterloo & Co (GMO)’s Cantel Medical Corporation CMD Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-585,765
Closed -$46.8M – 898
2021
Q1 		$46.8M Buy
+585,765
New +$45.7M 0.26% 65

Grantham, Mayo, Van Otterloo & Co (GMO)'s CMD Position: Q2 2021 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 585,765 shares — an estimated $46.8M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CMD in Q1 2021 and held it in 1 quarter. The position peaked at $46.8M in Q1 2021. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 585,765 Cantel Medical Corporation shares in Q2 2021, an estimated $46.8M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Cantel Medical Corporation in Q1 2021 and held it in 1 quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Cantel Medical Corporation position peaked at $46.8M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2021, filed 12 Aug 2021.